‍

Medical care for injured warfighters is quickly changing from field stabilization and rapid evacuation during the Global War on Terror, to prolonged and complex care in the field or underground. In Ukraine, getting a wounded soldier from the point of injury to advanced medical care can take days – sometimes more than a week – because constant drone surveillance and targeting makes evacuation extremely difficult. Compare that to Iraq and Afghanistan, where serious casualties could often reach higher-level care within an hour. That's not a small shift, and it calls for a drastic change in how we approach operational medicine.

When care has to stretch from minutes to days, and resupply logistics are challenging, key design principles about the equipment must change too. Devices need to be smaller, lighter, and more power efficient. They need to survive being dragged through mud, dropped, and run continuously for days without failing. The consumables should be as “universal” as possible to maximize supply flexibility, and reusability should be prioritized when appropriate. Devices also need simple user interfaces and workflows, because the lay or skilled medic should not be saturating cognitive bandwidth when caring for the injured. Lastly, but importantly, there is increasing recognition that medical devices could be a source for targeting and thus optimizing heat, light, or radio signatures must be considered.

We are at a unique point in history where a dramatic convergence of technological innovations offers emerging solutions to save injured warfighters’ lives despite these evolving battle circumstances. Here's the problem: almost none of the commercial medical technology relevant for these situations is designed to overcome the challenges of being used outside of very controlled environments. And bespoke technology developed with a specific government requirement in mind is often obsolete by the time it is delivered.

At IQT, we believe the best solutions to these complex challenges will come from existing commercial products that are properly vetted and adapted for operational environments.

‍

Great tech, wrong test

Commercial medical devices go through rigorous testing, but that testing is built around scientific validation and regulatory approval, not battlefield reality. A device gets validated in a lab or a clinical setting, under conditions that are about as far from a contested front line as you can get. That process tells you whether something is scientifically sound. It tells you almost nothing about whether it'll survive a rucksack, a firefight, or 48 straight hours of use.

Promising innovations in hemorrhage control, resuscitation, and emerging battlefield life support exist right now. But by the time they've cleared the regulatory bar and made it onto the market – the point where military users are typically even allowed to test them – limited if any stress-testing has evaluated whether they'll actually hold up where they're needed most. Any design flaws that show up under real operational stress get discovered far too late, after the product is already built and approved, and re-engineering subsequent clearances/approvals can take time we do not have.

‍

Why the answer is testing earlier, together

This is where the case for public-private partnership becomes pretty clear: startups building this technology don't have access to operational environments, and they have no real incentive to build for them, since their commercial customers may not fully prioritize rugged, low-signature, minimal-cognitive-load gear.

Neither side can close that gap alone. But a partnership that connects early-stage medical companies with operational end-users before a product is finalized can. This is already happening in special operations communities, but the challenge is providing feedback that avoids creating too bespoke of a device. IQT believes the commercial need is still critical and ensures the survival of the company, and early operational feedback can be essential to allow for the optimal product to be a game changer in both worlds. Getting real feedback into the design process early means the rucksack-fit problem, the battery-life problem, the “this takes too much concentration to use safely” problem, all get caught and fixed while the product can still be changed, not after it's already in the field.

And this isn't a one-way street where government simply extracts free R&D from startups. The feedback loop runs in both directions. Features that make a device tougher, simpler, and less mentally taxing to use in a warzone tend to be useful in emergency medicine, disaster response, and plenty of civilian settings too. The best technology coming out of this process is not purely a military tool with a government price tag – it's a better product overall, with a market that extends well beyond any one customer.

‍

What "good" actually looks like

None of this means throwing out the fundamentals. Scientific validity still matters – a device needs credible outside validation before anyone puts it near a casualty. Business fundamentals still matter too: does the company have a sustainable model, a real team, and a realistic path through the regulatory and geopolitical landscape it's operating in?

What changes is adding a third consideration alongside the scientific validity and business fundamentals: operational functionality. Does the tool work in the environment it's meant for? Can pre-field testing catch dangerous signatures or safety issues before anyone touches it? Do realistic simulations reveal that a device is too heavy, too complicated, or too fragile for the job? Those are the questions that only show up when you test early and test in the right context, not after a product has already been finalized.

‍

The bigger picture

This is really a story about timing. The startups building tomorrow's combat medical technology are moving fast, but they're building somewhat blind to the environment their product will actually face. Government operators understand that environment intimately, but they've historically had no seat at the table until it's too late to meaningfully shape the product.

IQT exists to close exactly that kind of gap – not only by writing checks, but by acting as a bridge that lets startups build with real operational insight from day one, and giving the combat care providers the tools built for the job in front of them. As warfare keeps evolving and the pace of innovation continues to accelerate, that bridge is going to matter more, not less.

‍